SuperNO2VA™ and General Anesthesia Postoperative Care

NAUnknownINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

October 15, 2018

Primary Completion Date

October 15, 2019

Study Completion Date

October 15, 2019

Conditions
HypoxemiaAcute Respiratory Failure
Interventions
DEVICE

SuperNO2VA nasal positive airway pressure devic

SuperNO2VA nasal positive airway pressure device utilizes supplemental oxygen and an adjustable pressure limiting valve to maintain upper airway latency

DEVICE

Supplemental oxygen

5lpm of supplemental oxygen

Trial Locations (1)

77030

RECRUITING

The University of Texas, MD Anderson Cancer Center, Houston

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

M.D. Anderson Cancer Center

OTHER

lead

Vyaire Medical

INDUSTRY

NCT03969615 - SuperNO2VA™ and General Anesthesia Postoperative Care | Biotech Hunter | Biotech Hunter